Technical Analysis for CPRX - Catalyst Pharmaceutical Partners, Inc.

Grade Last Price % Change Price Change
grade B 4.94 -1.59% -0.08
CPRX closed down 1.59 percent on Friday, July 10, 2020, on 54 percent of normal volume.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Up
Historical CPRX trend table...

Date Alert Name Type % Chg
Upper Bollinger Band Walk Strength 0.00%
Overbought Stochastic Strength 0.00%
Upper Bollinger Band Walk Strength -1.59%
Outside Day Range Expansion -1.59%
Overbought Stochastic Strength -1.59%
Upper Bollinger Band Touch Strength -1.59%
Stochastic Sell Signal Bearish -2.76%
Upper Bollinger Band Walk Strength -2.76%
Overbought Stochastic Strength -2.76%
Up 3 Days in a Row Strength -2.76%

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Catalyst Pharmaceutical Partners, Inc. operates as development-stage specialty pharmaceutical company. It focuses on the development and commercialization of novel prescription drugs targeting rare (orphan) neuromuscular and neurological diseases and disorders. The company's principal product includes Firdapse that is in Phase III clinical trial for the treatment of Lambert-Eaton Myasthenic Syndrome. It also develops CPP-115, a GABA aminotransferase inhibitor for the treatment of epilepsy and other selected central nervous disease indications; and CPP-109 for the treatment of Tourette Syndrome. Catalyst Pharmaceutical Partners, Inc. has strategic collaboration agreement with BioMarin. The company was founded in 2002 and is based in Coral Gables, Florida.
Health Pharmaceutical Pharmaceutical Industry Medication Disorders Virotherapy Health Sciences Epilepsy Pharmaceutical Sciences Biomarin Pharmaceutical Lambert Eaton Myasthenic Lambert Eaton Myasthenic Syndrome Novato Tourette Syndrome Treatment Of Epilepsy

Is CPRX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 7.67
52 Week Low 2.55
Average Volume 1,777,098
200-Day Moving Average 4.46
50-Day Moving Average 4.60
20-Day Moving Average 4.68
10-Day Moving Average 4.83
Average True Range 0.23
ADX 14.76
+DI 21.96
-DI 13.27
Chandelier Exit (Long, 3 ATRs ) 4.49
Chandelier Exit (Short, 3 ATRs ) 4.70
Upper Bollinger Band 5.17
Lower Bollinger Band 4.20
Percent B (%b) 0.76
BandWidth 20.69
MACD Line 0.13
MACD Signal Line 0.10
MACD Histogram 0.0375
Fundamentals Value
Market Cap 417.69 Million
Num Shares 84.6 Million
EPS -0.20
Price-to-Earnings (P/E) Ratio -24.70
Price-to-Sales 0.00
Price-to-Book 6.97
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 5.24
Resistance 3 (R3) 5.26 5.19 5.19
Resistance 2 (R2) 5.19 5.12 5.18 5.17
Resistance 1 (R1) 5.07 5.07 5.03 5.04 5.15
Pivot Point 4.99 4.99 4.98 4.98 4.99
Support 1 (S1) 4.87 4.92 4.83 4.84 4.73
Support 2 (S2) 4.80 4.87 4.78 4.71
Support 3 (S3) 4.67 4.80 4.69
Support 4 (S4) 4.64